A new model of implant-related osteomyelitis in the metaphysis of rat tibiae by unknown
RESEARCH ARTICLE Open Access
A new model of implant-related
osteomyelitis in the metaphysis of rat tibiae
Norbert Harrasser1*, Johannes Gorkotte1, Andreas Obermeier1, Susanne Feihl2, Melanie Straub4,
Julia Slotta-Huspenina4, Ruediger von Eisenhart-Rothe1, Walter Moser5, Philipp Gruner6, Michael de Wild7,
Hans Gollwitzer1,3 and Rainer Burgkart1
Abstract
Background: Animal models serve as an important tool to understand peri-implant infection. Most of the models
use high bacterial loads (>104 colony forming units, CFU) to provide high infection rates. Therefore these animals
evolve rather similarly, making comparison between groups and statistical analysis possible. On the other hand, to
mimic clinical constellation of surgery-related infections the use of low amounts of bacteria would be more
advantageous.
Methods: We developed a metaphyseal rat model of peri-implant bone infection with low amount of bacterial
loads (102 and 103 CFU of Staphylococcus aureus) and investigated osseointegration of the implants coated with
hydroxyapatite (HA) and low-dosed HA-silver (HA-Ag). Non-infected implants served as controls. After 6 weeks rats
were sacrificed and implants evaluated for osseointegration and infection.
Results: Infection of implanted devices was reliably induced, independently whether 102 or 103 CFU of S. aureus
were inoculated and HA or HA-Ag coated implants were used. No systemic infection was present in any of the
animals at the time of sacrifice, and no animal developed acute infection requiring premature sacrifice. All CFU
counts of the implant and the bone at sacrifice were significantly higher than the inoculated load (p < .05). All
sterilely inserted implants showed excellent osseointegration and no infection.
Conclusions: Our present study of a rat tibia model reliably induced osteomyelitis in the metaphysis with low-
doses of bacteria. The addition of low-dosed Ag to the implant coating was not able to reduce the infection rates.
The results demonstrate that it is possible to develop a model of implant-related osteomyelitis in rats with low
amounts of bacteria to better mimic clinical constellations. No other promoters of infection besides insertion of the
screw implant were used in this model.
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Background
Peri-implant infections (PII) are serious complications in
orthopedic surgery, representing a significant healthcare
and economic burden [1]. Management of these infec-
tions often requires multiple staged surgeries and the
use of antibiotics as a supportive therapy for eradication
[2, 3]. Up to day several factors in the pathogenesis and
treatment of implant-related bone infections are still un-
clear. Animal models are therefore considered helpful
for understanding mechanisms of implant-associated
osteomyelitis as well as in-vivo testing of potential anti-
infective implant coatings and antibiotics. Consequently,
a number of different models of PII have been developed
[4–9]. A major problem in this context is that several
crucial parameters (e.g. bacterial load, bacterial strains,
implant configuration, implant location) differ between
the various models making comparison among each
other difficult. The amount of seeding bacteria is subject
to controversial debates. To promote signs of infection,
usually bacterial counts far beyond 103 colony forming
units (CFU) have been used [4, 8, 10, 11]. This creates
high rates of infection in nearly all animals but on the
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other hand is not very helpful to mimic clinical constella-
tion of surgery-related infections. Another disadvantage of
various animal models is the fact that osseointegration
usually cannot be evaluated. If K-wires, plates or even arti-
ficial joints are used as implants removal of these devices
usually can’t be quantified and no statement can be made
whether osseointegration took place or not. Finally, many
documented animal models of peri-implant bone infec-
tions used diaphyseal implant positioning. However, meta-
physeal fixation is more common in the clinical use of
orthopedic implants [6, 10, 12, 13].
Hence, the aim of the present study was to evaluate a
novel animal model mimicking infection with low
amounts of bacterial inocula at the level of the tibial
metaphysis. For generation of implant-associated infec-
tion the amount of bacteria was tested as an independ-
ent parameter (Staphylococcus aureus; 102 vs. 103 CFU).
Additionally, investigation of osseointegration of the de-
vice was carried out in a semiquantitative manner.
Methods
Implants
The implant used in the present study was a custom-
made titanium (Ti6Al4V) screw (Fig. 1). The screw was
coated with HA and HA-Ag (Atesos medical AG, Aarau,
Switzerland; Medicoat AG, Mähenwil, Switzerland) ac-
cording to a manufacturing process previously described
(Fig. 2) [14]. Briefly summarized, a modified technique
of Vacuum Plasma Spraying (VPS) coating was used so
that a thickness of ~100 μm was achieved for the coat-
ings. The HA-Ag coating contained low amounts of Ag
(45 ppb). The morphology of the surface was analyzed
by Scanning electron microscope (Hitachi TM-3030Plus)
using secondary electron detector. The surface rough-
ness was determined on the apical position of the im-
plant by Confocal Laser Scanning Microscope (Lext
OLS 3100, Olympus) equipped with a 50× objective. The
Ra-1D-values were determined by averaging n = 10 pro-
files of length 260 μm, using a cut-off wave-length of
26 μm. The SRa and SRz-2D-values were defined of n = 5
areas of 295 × 20 μm2 also applying a cut-off wave-length
of 26 μm. Due to the HA-VPS-coating, the surface of both
implants showed a rough surface morphology with con-
sistent arithmetic average roughness Ra of 2.49 ± 0.62 μm
for group I (HA) and 2.21 ± 0.47 μm for group II (HA-Ag)
surface moodification. The 2D surface rouhness parame-
ters SRa (arithmetic average roughness) and SRz (max-
imum height) listed in Table 1 were also identical for both
groups. The coarse surface topography was observed in
the SEM image showing a homogeneous VPS-coating for
either groups (Fig. 3).
Bacterial strains and preparation of inocula
The bacterial strain selected in the study was one of the
most common causative pathogens associated with PII,
namely S. aureus (ATCC25923, LGC Standards GmbH,
Wesel, Germany). The strain was routinely cultured in
Columbia Agar with 5 % sheep blood (Becton Dickinson,
Heidelberg, Germany) at 37 °C overnight before testing.
Bacteria were then harvested by centrifugation, rinsed,
suspended, diluted in sterile phosphate buffered saline
(PBS) and adjusted by densitometry (MacFarland Densi-
mat™, BioMérieux, Marcy l’Etoile, France). For the study
every suspension with its known bacterial concentration
was diluted with NaCl to reach the targeted value for
bacterial concentration (Group I-IIA: 102 CFU/10 μl,
Group I-IIB: 103 CFU/10 μl). In order to obtain log-
phase growth over-night freezing of strains was strictly
avoided and incubation of bacteria at 37 °C throughout
the preparation time was conducted. To quantify the
bacterial load prior to inoculation serial dilutions of the
residual suspensions were incubated on agar plates for
48 h at 37 °C, and the number of inoculated viable cells
was then calculated.
Fig. 1 SEM image of the coated screw implant (diameter = 3.5 mm; length = 5 mm)
Harrasser et al. BMC Musculoskeletal Disorders  (2016) 17:152 Page 2 of 11
Animals and surgical procedure
The study was approved by the Animal Experimentation
Ethics Committee of Bavaria (Reg. No. 146-14) and was
conducted with reference to the OECD Principles of Good
Laboratory Practice. According to the committee’s recom-
mendation that the number of experimental animals be
minimized, the sample was limited to 12 rats per group
and both tibiae were used for study purposes. Hence, 24
male, 5-month-old Wistar rats (Charles River Laborator-
ies, Sulzfeld, Germany) with a mean body weight (BW) of
378.6 g (range: 353–401 g) were used. For acclimatization,
the animals were delivered to the animal facility at least 1
week prior to treatment. Animals were housed in cages
(2-5 animals) at normal room temperature and daylight il-
lumination with ad libitum access to food and water.
Surgery was performed under general anesthesia in-
duced by weight-adapted intramuscular injection of
Medetomidin (150 μg/kg BW), Midazolam (200 μg/kg
BW) and Fentanyl (5 μg/kg BW). Blood was collected by
puncture of the tail vein prior to surgery.
Animals were prepared for surgery as follows (Fig. 4):
Both hind legs were shaved, antisepticized with povi-
done–iodine, and dried. Bodies were covered with sterile
sheets except for the hind legs. A skin incision (length,
1–2 cm) was made over the proximal lateral tibial meta-
physis. A unicortical hole with a depth of ~8 mm was
drilled using a 1.8 mm diameter drill bit. The drill hole
was then tapped with a custom-made stainless steel tap
and dried with gauze. After removal of the gauze 10 μl
of either sterile PBS (left tibia = control) or PBS/S. aur-
eus in the entitled concentrations (right tibia = infected)
were injected into the hole with a 25 μl microsyringe
(Hamilton, Reno, NV). The implant was inserted into
the cavity immediately after injection of the solutions
using a dedicated instrument. Soft tissue was irrigated
with saline solution, the fascia was closed using absorb-
able suture material (Vicryl rapid, Ethicon Inc.,
Cincinnati, USA; size 6-0), the skin was closed by
continuous intracutaneous (4-0 Monocryl, Fa. Ethicon,
Norderstedt, Germany) and interrupted sutures (4-0
Prolene, Fa. Ethicon, Norderstedt, Germany). Anesthesia
was antagonized after surgery by a subcutaneous injec-
tion of 750 μg/kg BW atipamezol (Alzane, Pfizer, Berlin,
Germany), 200 μg/kg BW flumazenil (Flumazenil-ratio-
pharm, Ratiopharm, Ulm, Germany) and 120 μg/kg
BW naloxone (Naloxon-Ratiopharm, Ratiopharm, Ulm,
Germany). Metamizole (110 mg/kg BW) was administered
subcutaneously (s.c.) at the beginning of the surgery.
Additionally, buprenorphine (0.05 mg/kg BW) was ad-
ministered at the end of the surgical procedure
immediately before the wound closure was completed.
Postoperative pain control was also carried out with
buprenorphine (0.05 mg/kg BW s.c., 2 x daily) for
2 days. In addition, meloxicam was given s.c. immedi-
ately postoperatively and then followed for days 1–3
every 24 h at a dose of 1 mg/kg BW.
Rats were divided into two groups according to the
type of implant inserted (Table 2).
Sacrifice
The animals were sacrificed after 42 days. Under general
anesthesia 3 ml of blood was collected by puncture of the
right atrium and a lethal dose of pentobarbital (80 mg/kg
BW) was injected. Tibiae of both hind legs, starting with
the control site (left) were dissected under sterile condi-
tions and further investigations were conducted.
Radiographic evaluation
Radiographs were taken in two planes immediately after
implantation and on the day of sacrifice. For X-rays, digital
films (DLR Cassette, Digiscan 2H/2C, Siemens) and a
Mobilett Plus X-ray unit (Siemens AG, Erlangen, Germany)
were used. Three regions of interest (ROIs) were deter-
mined (R1, epiphysis; R2, metaphysis with implant; R3,






Fig. 2 Coating structure of HA (left) and HA-Ag (right)
Table 1 Surface roughness (mean score values ± standard
deviation) of the implant
Ra [μm] SRa [μm] SRz [μm]
Group I (HA) 2.49 ± 0.62 2.98 ± 0.24 117.38 ± 10.74
Group II (HA-Ag) 2.21 ± 0.47 3.22 ± 0.80 105.03 ± 12.07
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Parameters 1–4 ranged from 0 (absent), 1 (mild) to 2
(severe), and were evaluated separately for ROIs 1–3.
Parameter 5 was evaluated for present or not present. If
the implant was loose the average score for parameters
1–4 was doubled. The maximum score possible was 48
(3 ROIs × 4 parameters × 2 points × 2 for loose implant).
We did not perform radiological evaluations in the acute
phase (first weeks after operation) as most radiological
signs of bone infection are not apparent in this phase
and therefore an additional general anesthesia for the
animals would be of minor scientific benefit [6].
Evaluation of osseointegration
The screw was removed manually using a sterile
custom-made screwdriver and afterwards investigated
macroscopically for attached bone remnants. Resistance-
to-removal (RTR) was evaluated semiquantitatively, at-
tached bone remnants (ABR) were scored quantitatively.
The following scoring system ranging from 1–5 points
for either items (RTR and ABR) was applied (Table 3,
Fig. 5). Means of either values (RTR and ABR) were
summarized and osseointegration-score was calculated
accordingly (range: 2–10). Additionally, two sterilely
Fig. 3 SEM analysis (backscattered electron detector) of both surface types before and after implantation
Fig. 4 Operative procedure (left tibia): a Skin incision at the anterolateral aspect of the proximal tibia, b visible proximal tibia after blunt
dissection of soft tissues, c drilling and tapping of unicortical hole, d injection of PBS (left tibia = control site), e insertion of implant (screw not yet
full countersinked), f skin closure with intracutaneous and interrupted sutures
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inserted implants of group I (HA) and II (HA-Ag) were
randomly chosen and not removed but histologically
evaluated for osseointegration [15]. Specimens were sec-
tioned by a diamond band saw (Exakt 300P) in the mid-
dle of the implant, glued to a support, and sectioned
again, so that a 200 mm-thick sample from the middle
was attached to the support. The thickness of this sam-
ple was further reduced to 40–60 mm by a grinding
machine (Exakt 420 CS). To visualize tissues, the
samples were surface stained by toluidine blue.
Microbiological evaluation
Examination of bacteriology swabs
Bacteriology swabs from the subcutaneous tissue and the
implant site were obtained bilaterally of all animals. Swabs
were moistened with one drop (20 μl) of sterile PBS, then
evenly streaked onto a plate each of Columbia-Agar and
Schaedler-Agar, and immersed in thioglycollate broth.
The solid and liquid media were incubated for 48 h at the
below mentioned conditions:
 Columbia-Blood-Agar (BD): 37 °C
 Schaedler-Agar (BD): 37 °C under anaerobic
conditions
 Thioglycollate broth (prepared in-house): 37 °C
After 48 h the solid and liquid media were analyzed by
conventional bacteriological techniques. The identity of
S. aureus isolates was determined by catalase and coagu-
lase testing or by matrix-associated laser desorption/
ionization-time of flight mass spectrometer (MALDI-
TOF, Bruker Corporation, Billerica, U.S) if the catalase/
coagulase testing was unclear.
Examination of the implant
Implant-adhering bacteria were detached from the
implant immersed in 1 ml PBS using low frequency
ultrasound treatment (Sonorex digital 10P, Bandelin,
Berlin, Germany: 5 min. at 80 % intensity). After the
treatment, tubes were centrifuged at 4000 rpm for
10 min. at 4 °C temperature (Heraeus Varifuge 3.OR;
Kendro Laboratory Products, Osterode, Germany). The
supernatant was resuspended in 300 μl PBS. A serial
tenfold dilution of this irrigated PBS was incubated on
agar plates at 37 °C for 48 h, and the number of inocu-
lated viable cells was then calculated.
Examination of peri-implant bone
Adhering soft tissues were removed from the tibia, and
the remaining bone was ultrasonically irrigated in 10 ml
of PBS for 5 min. A serial tenfold dilution of this irri-
gated PBS was incubated on agar plates at 37 °C for
48 h, and the number of inoculated viable cells was then
calculated.
Histological evaluation of infection
One randomly chosen tibia from each group (IA/B, IIA/
B; one from the control site, one from the infected site
= totally eight specimens) was fixed for two days in 5 %
formaldehyde and decalcified in 5 % nitric acid solution.
The tibia was embedded in paraffin and cut into 4 mm
thick sections. Slices were stained with haematoxylin/
eosin. Three ROIs according to the radiographical evalu-
ation were analyzed on [7, 12]:
1. Infiltration of granulocytes
2. Sequestrum formation
3. Infiltration of mononuclear cells and bone marrow
fibrosis
4. Enlargement of cortical bone
5. Erosion/destruction of cortical bone
6. General impression
Parameters 1 to 5 were scored with 0 (absent) or 1
(present). Parameter 6 was scored from 0 (absent), 1
(mild) to 2 (severe). The maximum score was 21. (3 ×
ROIs (parameter 1–5) × max. 1 point + 3 × ROI (param-
eter 6) × max. 2 points).
Statistics
All results are presented as means ± standard deviation
(SD). Statistical significance was computed using non-
Table 2 Main features of testing groups
Group IA IB IIA IIB
Implant coating HA HA-Ag
Right tibia: S. aureus (CFU) 102 103 102 103
Left tibia: S. aureus (CFU) 0 0 0 0
Number of animals 6 6 6 6
Table 3 Scoring system for resistance-to-removal (RTR) and attached bone remnants (ABR)
Score RTR ABR
1 Loose screw can be removed with forceps only No bone detectable on implant
2 Little resistance (only tip of 2 fingers needed to hold screwdriver) Traces of bone remnants on implant
3 Moderate resistance (screwdriver held in pinch grip) Thin bone layer on implant (10–25 % of surface coated with bone)
4 Strong resistance (like 3 but more power needed) Moderate bone layer on implant (25–50 % of surface coated with bone)
5 Bone fracture with screw partly covered by bone Thick bone layer on implant (>50 % of surface coated with bone)
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parametric methods and the method of closed testing
procedure (Kruskal-Wallis test, Mann-Whitney U test,
Wilcoxon test). P < 0.05 was considered statistically sig-
nificant. Statistical tests were performed with use of
SPSS (version 20.0; Chicago, Illinois).
Results
Clinical evaluation of animals
The animals recovered quickly after surgery and showed
no signs of discomfort. There was no statistically signifi-
cant difference in mean weight gain between the groups
if the inoculated bacterial load was considered (Group I/
IIA: 30 ± 11 g, Group I/IIB: 23 ± 17 g).
Blood analyses
The course of hemoglobin (day of surgery vs. day of sacri-
fice) showed no significant difference between the groups
throughout the experimental period. Further, infect pa-
rameters (white blood cell count, platelets) showed no
significant elevation at day of sacrifice (Table 4).
Microbiological evaluation
Day of surgery
Plate counts of bacterial suspension revealed an average
number of inoculated viable cells for the right tibiae of
1.43 × 102 CFU/10 μl (±16.1) for Group A (Target:
102 CFU), and 0.89 × 103 CFU/ml (±40.5) for Group B
(Target: 103 CFU). The difference between the two
groups was statistical significant.
Day of sacrifice
50 % of cultures obtained from bacteriological swabs
from the implant surface, and ~20 % of the swabs taken
from the subcutaneous tissue in groups of infected ani-
mals were positive for S. aureus (Table 5). On the other
hand, 100 % of cultures from bone and implant were
positive. Coagulase/catalase testing and MALDI-TOF
evaluation revealed the same strain as inoculated in all
tested animals. Average bacterial counts from the bone
site of infected groups (I: HA, II: HA-Ag) were signifi-
cantly lower compared to bacterial counts from the im-
plant site (Table 6). Regarding the bacterial amount
harvested from the osseous site highest counts were
found in tibiae from group IIB, followed by group IIA,
group IA and group IB. Taken into account that groups
with HA-Ag (IIA/B) did not show less bacterial growth
at sacrifice compared to groups with HA (IA/B) a correl-
ation between inoculation loads of groups A (102 CFU)
and groups B (103 CFU) and loads at sacrifice was not
found. Therefore, the amount of inoculated staphylo-
cocci on day of surgery did not correlate with the
amount of bacteria at day of sacrifice (Table 6).
In control groups I-IIA/B for the left tibiae no bacter-
ial growth could be observed on any implant cultures or
from sonicated fluids of the bone. Additionally, all
smears were found to be negative.
Histological evaluation of infection
All retrieved specimens of the control sites of groups I-
IIA/B (inoculated PBS) showed no signs of bone infection
Fig. 5 Scoring of osseointegration (Note: shaded area in red indicates bone on implant surface after explantation of the screw)
Table 4 Number (mean ± standard deviation) of leucocytes = white blood cells (WBC), erythrocytes = red blood cells (RBC), and
platelets in blood samples on day of surgery (day 1) and at sacrifice (day 42)
Parameter Group IA (102 CFU) Group IB (103 CFU) Group IIA (102 CFU) Group IIB (103 CFU)
Day 1 Day 42 Day 1 Day 42 Day 1 Day 42 Day 1 Day 42
WBC (×103/l) 9,23 ± 1,98 7,53 ± 1,97 9,33 ± 3,71 6,05 ± 1,80 9,07 ± 1,98 7,87 ± 3,22 9,62 ± 2,62 8,57 ± 3,59
RBC (×106/l) 8,27 ± 0,76 8,64 ± 0,95 7,13 ± 2,40 8,55 ± 1,08 8,21 ± 1,41 8,38 ± 0,67 8,19 ± 1,29 6,34 ± 5,66
Platelets (×103/l) 834,5 ± 189,25 628,33 ± 237,56 717,83 ± 406,97 599,83 ± 528,47 912,17 ± 135,77 649,00 ± 321,04 763,33 ± 290,16 751,50 ± 343,20
Note: No statistical significant difference regarding various parameters of different groups was found between day 1 and 42
*p < 0.05 in groups between day 1 and day 42
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(Table 7). In these groups large amount of newly formed
bone around the implants and in contact with the implant
surface were observed suggesting good biocompatibility of
the implants. All histological slices from infected sites
showed typical signs of chronic bone infection (Fig. 6). In-
fection signs were only detectable in ROIs 1 (epiphysis)
and 2 (metaphysis). Mean score value of control sites
(PBS) was zero. Due to the small sample size per group no
statistical analysis was conducted (Table 7).
X-ray examinations at day of sacrifice
X-rays of all infected sites revealed radiographic signs of
osseous destruction in ROIs 1 (epiphysis) and 2 (meta-
physis). No signs of infection were detected in ROI 3
(proximal diaphysis). Osteolysis, soft-tissue swelling and
implant loosening were the most common findings,
sequestrum formation and periosteal reaction on the
other hand was never observed. In contrast to infected
sites, X-rays of the control sites showed no signs of
osteomyelitis (Fig. 7, Table 7).
Osseointegration
All implants of the control site showed excellent
osseointegration with average score values ranging from
4 to 5. All infected sides on the other hand showed poor
resistance to screw-out. Values ranged from 2 to 3. The
differences between the groups were statistically signifi-
cant (Table 7). Evaluation of osseointegration by hist-
ology showed broad bone integration throughout the
whole surface of HA and HA-Ag implants (Fig. 8).
Discussion
Many models of implant-associated infection in rats,
mice, and rabbits have some significant limitations:
Firstly, several studies investigated intramedullary nail
implants or plates positioned at the level of the diaphysis
and therefore restricted their findings mainly on situa-
tions from trauma surgery. However, a majority of bone
and joint implants are fixed in the metaphyseal region
[11, 16–18]. Secondly, bacterial loads used in several
models are usually high and therefore don’t mimic clin-
ical constellations [5, 7, 12, 16]. Thirdly, few infection
models exist where osseointegration of implants can eas-
ily be investigated [9]. Therefore, the aim of the present
work was to create an animal model where these limita-
tions are overcome and findings are conferrable to infec-
tions associated with orthopedic implants. Additionally,
impact on osseointegration and antibacterial effect of a
low concentrated antibacterial coating on the implant
was investigated.
The design of the implant we chose in the present
study has some important features (Fig. 1): The diameter
of the most superficial threads is larger than the diam-
eter of the drill and the thread cutter, and therefore al-
lows the implant to be implanted “press-fit”, the most
common used method of fixing cementless orthopedic
devices. In addition, the cone-shaped profile provides
sealing of the drilled hole with the inserted bacteria. In
several models bone wax, fibrin glue or dental gypsum are
applied to seal the site of application in order to prevent
bacterial leakage into the surrounding tissue [4, 19, 20].
This leakage is a major problem if K-wires or other rods
are inserted into the medullary cavity of long bones, since
Table 5 Microbiological results and bone weight of right tibiae (infected) determined on day of sacrifice; a positive tested on
S. aureus
Groups
IA (HA, n = 6) IB (HA, n = 6) IIA (HA-Ag, n = 6) IIB (HA-Ag, n = 6)
Cultures of subcutaneous smears Positivea 1 1 2 1
Cultures of implant surface smears Positivea 2 3 3 4
Cultures of implant Positivea 6 6 6 6
Cultures of peri-implant bone Positivea 6 6 6 6
Bone weight [mg] 504 ± 27 498 ± 37 456 ± 67 546 ± 78
Table 6 CFU values (mean ± standard deviation) at implantation day (Inoculum) and day of sacrifice of the implant and the
periprosthetic bone; p-values are given for comparison Inoculum/Implant and Implant/Bone





IA (HA) 102 1.16x102 ± 75 116.1x 103 ± 112x103 <.05 21.5x103 ± 29.3x103 <.05
IIA (HA-Ag) 102 1.71x102 ± 52 392.2x103 ± 641x103 <.05 30.2x103 ± 38.3x103 <.05
IB (HA) 103 0.97x103 ± 221 302.2x 103 ± 298x103 <.05 8.2x103 ± 3.9x103 <.05
IIB (HA-Ag) 103 0.83x103 ± 278 119.3x 103 ± 161x103 <.05 60.9x103 ± 55.1x103 <.05
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bleeding out of the bone can lead to a washing-out of bac-
teria that have been inoculated previously. Additionally,
the implant we used is solid at the top and not hollow as
described by other authors [4]. The disadvantage of hol-
low implants, besides the fact that they provide a contami-
nated “dead space” not accessible for host defense
mechanisms, is that again bacteria can be washed-out by
bleeding from the bone site. To avoid this, again the hole
has to be sealed, e.g. by bone wax, which on the other
hand is another foreign material potentially influencing
bacterial growth. Finally, the placement of the implant
in the present study was decided to be in the metaphy-
sis close to the joint. This part of the bone is highly
interesting for orthopedic questions regarding joint re-
placement and has been used in rats only by few au-
thors so far [4, 5, 12].
In the present study we were able to create osteomye-
litis in all infected tibiae with low amounts of bacteria
(102 and 103 CFU). Numerous animal models creating
osteomyelitis in rats, mice, and rabbits are using rather
high bacterial concentrations (>103 CFU) in order to
create high numbers of infected animals [4, 9, 21–26].
The advantage in these studies is that nearly all animals
develop infection and therefore evolve rather similarly,
making comparison between groups and statistical
analysis possible. However, the big disadvantage is that
high bacterial loads do not mimic clinical constellations,
neither of primary nor revision surgery. Even after eradi-
cation of PII and reimplantation of an orthopedic implant
a rather sterile environment and only small amounts of re-
sidual, undetectable bacteria have to be assumed. There-
fore, it is difficult to consider animal models creating
infections by using inoculation loads far beyond 103 CFU
as studies mimicking clinically relevant situations. On the
other hand, as shown in the present study, if low amounts
of bacteria are used according to our approach local infec-
tion can reliably be induced. In this context, there are
mainly three possible reasons why our model achieved
those high rates of osteomyelitis: 1) The “catching effect”
of the screw implant on the bacterial solution prevented
loss of bacteria into the surrounding tissue. 2) The bacter-
ial strain: S. aureus (ATCC25923) seems to be well suited
for infect models as it was previously reported with high
rates of osteomyelitis in an animal model [4]. Many other
authors used different strains of S. aureus with consider-
ably lower rates of infections [9, 10, 12, 16, 27]. 3) In the
preparation of bacterial inocula we strictly avoided freez-
ing of aliquots the day before implantation. This allows
bacteria to be in maximum logarithmic growth at time of
surgery and prevents from injecting bacteria not being
active enough to resist the host’s antibacterial defense
mechanisms.
Another finding in our study was the fact that we were
able to establish constant bacterial presence on the implant
Table 7 Outcome of radiographic and histologic assessment and osseointegration (mean score values ± standard deviation)
Groups IA (HA) IB (HA) IIA (HA-Ag) IIB (HA-Ag)
Left Right Left Right Left Right Left Right
CFU 0 102 0 103 0 102 0 103
Radiographic score 0 ± 0 16.5 ± 6.4* 0 ± 0 15 ± 5* 0 ± 0 15.8 ± 4.8* 0 ± 0 16.5 ± 3.3*
Histologic score 0 16 0 13 0 6 0 9
Osseointegration score 8.7 ± 0.5 5 ± 0.5* 9.7 ± 0.4 4.7 ± 0.5* 9.3 ± 0.5 5.3 ± 0.5* 9 ± 0.5 4.3 ± 0.4*
*p < 0.05 between right (infected) and left (sterile) tibiae of each group
Fig. 6 a Overview over epi-metaphysis and proximal diaphysis of a right tibia (inoculation with 102 CFU), showing subacute osteomyelitis (H&E
stain). b 25 x magnification of picture A, showing inflammatory infiltrate (asterisk), containing mononuclear cells and granulocytes, and bone
necrosis (black arrow) (H&E stain). c Bone erosion (black arrow) due to inflammatory infiltrate (asterisk) (15 x magnification, van Gieson’s stain)
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and the adjacent bone and could demonstrate growth to
common steady state value irrespective of the initial inoc-
ula, which differed by one order of magnitude (Table 6).
These results are supported by Haenle and can be ex-
plained by a consistent environmental situation in all cases,
meaning comparable nutritional supply and amount of
host defense mechanisms [4]. The results indicate the
achievement of a stationary phase of bacterial population
during implant infection without systemic illness – com-
parable to the so-called “low-grade” infection. Apparently,
this ultimate population size appears to be earlier reached
on the implant surface than the peri-implant bone
structures. Contradicting to these findings Lucke et al. re-
ported an inoculation-dose depending amount of bacteria
on the day of sacrifice [5].
The microbiological and histological evidence of infec-
tion in our study was only partially confirmed by radio-
logical investigations. It is well known that conventional
radiography is variable and unspecific in detecting osteo-
myelitis in early stages and therefore inferior to microbio-
logical and histological evaluation of implant-associated
infections, especially in cases where low bacterial concen-
trations are used to create infection [4, 28]. On the other
hand, if high bacterial loads are used X-ray examinations
Fig. 7 X-rays of tibiae in a.-p.-view at day of implantation (d = 0) and at day of sacrifice 6 weeks postop (d = 42). White lines mark regions of
interest separately assessed for scoring. R1, epiphysis; R2, metaphysis; R3, proximal diaphysis. a and b Right tibia of infected animal showing
signs of infection with osteolysis, and loose implant at day of sacrifice. c and d Left tibia (sterile) of an animal with no radiographic signs of
osteomyelitis or implant loosening
Fig. 8 Osseointegration examined by histology. The surface of the implants is entirely coated by a thin layer of newly formed bone (blue) which
is reached by trabeculae from the cancellous bone; HA (left), HA-Ag (right)
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can be quiet sensitive in depicting infection [6, 12]. A new
approach in visualizing infection-induced osteolysis with
higher sensitivity than conventional radiography can be
the use of microCT imaging [9].
A second focus of the present work was on the use of
low-dose Ag as an antibacterial additive on HA-coatings.
Low-dose Ag was used to possibly provide sufficient
osseointegration since the bactericidal activity of Ag has
been stated to be present at concentrations as low as
35 ppb [29]. Ag+ concentrations in the powder of the
HA-Ag coatings of the present study were 45 ppb and
therefore rather low. In this context, a previous study
evaluating similar coatings showed high bactericidal ac-
tivity of HA-Ag samples in-vitro at short time [14]. On
the other hand, still contradicting data exist regarding
the reproducibility of antibacterial effects of Ag in-vitro
and in-vivo showing that effects in-vitro do not neces-
sarily have to be evident in-vivo [24]. However, such Ag
coatings have rarely been applied to the surface of im-
plants in the region of direct bone contact because of
potential toxicity [13, 30]. To resolve this problem, we
used HA as a support material for Ag+, because it offers
good biocompatibility and osteoconductivity. Neverthe-
less, our study failed to show bactericidal effects of HA-
Ag compared to untreated HA implants (Tables 5 and 6).
However, all HA and HA-Ag implants of the sterile site
showed excellent osseointegration (Table 7, Fig. 8). The
sterilely inserted HA- and HA-Ag-screws were encapsu-
lated by dense bone after 6 weeks, similar to what has
been described previously around titanium implants
[31]. Results from conventional X-ray examinations re-
vealed that the same osseointegration as on HA-screws
took place around HA-Ag-screws (Table 7). This find-
ing was confirmed semiquantitatively by measurement
of resistance-to-removal. Histological examination re-
vealed no cellular inflammation or foreign-body granu-
loma around silver-coated implants of the control site,
trabeculae and bone cells were normal (Fig. 8).
We acknowledge limitations to our study. Firstly, we
used only one type of bacteria in this study. Antimicrobial-
coated implants should provide activity against not only
the most common causative bacteria (i.e., S. aureus) but
also other potential pathogens. However, it is impractical
to examine all pathogens. Secondly, our study is short-
term and it is difficult to speculate whether the localized
infection will show high-grade infection with sepsis in the
long term. The length of the study was according to most
authors studying implant-associated infection in animal
models and therefore comparable to other studies. Thirdly,
our biomechanical testing was semiquantitative by evaluat-
ing resistance-to-removal of the screws. This method was
chosen due to the small sample sizes of the groups where
quantitative measurements are difficult to state. Addition-
ally, even if quantitative methods are used (e.g., resonant
frequency analysis) correlation between biomechanical
testing and osseointegration is not always observed
[32, 33]. However, due to the fact that the screw with
its internal thread could be easily connected with a cus-
tomized torsiometer quantitative measurements would be
performable in future studies focused primarily on ques-
tions regarding osseointegration.
Conclusion
The findings of the present study highlight three main
features: 1) Inoculation of small amounts (102 and
103 CFU) of S. aureus around a screw-shaped implant in
the metaphysis of rat tibiae yielded to local infection in
all animals. These bacterial loads are closer to clinical
settings compared to inoculation of high doses exceed-
ing 103 CFU; 2) Excellent osseointegration of all im-
plants (HA and HA-Ag) was present at the uninfected
site indicating good biocompatibility of the coatings; 3)
No antibacterial effect of low-concentrated HA-Ag coat-
ings was found; 4) Presence of infection diminishes
osseointegration.
This animal model can be considered suitable for stud-
ies on the efficacy of prophylaxis, treatment, and patho-
genesis of implant-related infections of bone and may
serve for investigations analyzing the influence of various
implant surface properties on the development of bone
infection.
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